Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors - PubMed (original) (raw)
Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors
Hyung Shin Yoon et al. Neuropharmacology. 2008 Sep.
Abstract
It was previously reported that blockade of group II metabotropic glutamate receptors (mGluRs) produces hyper-locomotion in rats previously exposed to amphetamine, indicating that group II mGluRs are well positioned to modulate the expression of behavioral sensitization by amphetamine. The present study further examined the locomotor activating effects of specific blockade of these receptors after cocaine pre-exposures. First, rats were pre-exposed to seven daily injections of cocaine (15mg/kg, IP). When challenged the next day with an injection of either saline or the group II mGluR antagonist LY341495 (0.5, 1.0 or 2.5mg/kg, IP), they produced hyper-locomotor activity, measured by infrared beam interruptions, to LY341495 compared to saline in a dose-dependent manner. Second, rats were pre-exposed to either saline or seven daily injections of cocaine (15mg/kg, IP). Three weeks later, when they were challenged with an injection of either saline or LY341495 (1.0mg/kg, IP), only rats pre-exposed to cocaine produced hyper-locomotor activity to LY341495 compared to saline. These effects, however, were not present when dopamine D1 (SCH23390; 5 or 10microg/kg), but not D2 (eticlopride; 10 or 50microg/kg), receptor antagonist was pre-injected, indicating that this cocaine-induced hyper-locomotor activity to LY341495 may be mediated in dopamine D1 receptor-dependent manner. These results suggest that group II mGluRs may be adapted to interact with dopaminergic neuronal signaling in mediating the sensitized locomotor activity produced by repeated cocaine pre-exposures.
Similar articles
- Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
Kim WY, Vezina P, Kim JH. Kim WY, et al. Behav Brain Res. 2008 Aug 5;191(1):62-6. doi: 10.1016/j.bbr.2008.03.010. Epub 2008 Mar 16. Behav Brain Res. 2008. PMID: 18433894 - Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine.
Chi H, Jang JK, Kim JH, Vezina P. Chi H, et al. Neuropharmacology. 2006 Oct;51(5):986-92. doi: 10.1016/j.neuropharm.2006.06.008. Epub 2006 Aug 8. Neuropharmacology. 2006. PMID: 16901517 - Role of metabotropic glutamate receptors in the control of neuroendocrine function.
Durand D, Pampillo M, Caruso C, Lasaga M. Durand D, et al. Neuropharmacology. 2008 Sep;55(4):577-83. doi: 10.1016/j.neuropharm.2008.06.022. Epub 2008 Jun 20. Neuropharmacology. 2008. PMID: 18616955 Review. - Metabotropic glutamate receptors and epilepsy.
Ure J, Baudry M, Perassolo M. Ure J, et al. J Neurol Sci. 2006 Aug 15;247(1):1-9. doi: 10.1016/j.jns.2006.03.018. Epub 2006 May 11. J Neurol Sci. 2006. PMID: 16697014 Review.
Cited by
- Acute and chronic effects by nicotine on striatal neurotransmission and synaptic plasticity in the female rat brain.
Lucente E, Söderpalm B, Ericson M, Adermark L. Lucente E, et al. Front Mol Neurosci. 2023 Jan 12;15:1104648. doi: 10.3389/fnmol.2022.1104648. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36710931 Free PMC article. - Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.
de Bartolomeis A, Tomasetti C. de Bartolomeis A, et al. Mol Neurobiol. 2012 Oct;46(2):275-96. doi: 10.1007/s12035-012-8293-6. Epub 2012 Jul 5. Mol Neurobiol. 2012. PMID: 22763587 Review. - Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.
Moussawi K, Kalivas PW. Moussawi K, et al. Eur J Pharmacol. 2010 Aug 10;639(1-3):115-22. doi: 10.1016/j.ejphar.2010.01.030. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371233 Free PMC article. Review. - Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA. Bishop JR, et al. Psychopharmacology (Berl). 2015 Jan;232(1):145-54. doi: 10.1007/s00213-014-3649-4. Epub 2014 Aug 7. Psychopharmacology (Berl). 2015. PMID: 25096017 Free PMC article.